Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer

Failure to detect early-stage epithelial ovarian cancer (EOC) is a major contributing factor to its low survival rate. Increasing evidence suggests that different subtypes of EOC may behave as distinct diseases due to their different cells of origins, histology and treatment responses. Therefore, th...

Full description

Bibliographic Details
Main Authors: Meng-Shin Shiao, Jia-Ming Chang, Arb-Aroon Lertkhachonsuk, Naparat Rermluk, Natini Jinawath
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/10/1433
_version_ 1797515232998850560
author Meng-Shin Shiao
Jia-Ming Chang
Arb-Aroon Lertkhachonsuk
Naparat Rermluk
Natini Jinawath
author_facet Meng-Shin Shiao
Jia-Ming Chang
Arb-Aroon Lertkhachonsuk
Naparat Rermluk
Natini Jinawath
author_sort Meng-Shin Shiao
collection DOAJ
description Failure to detect early-stage epithelial ovarian cancer (EOC) is a major contributing factor to its low survival rate. Increasing evidence suggests that different subtypes of EOC may behave as distinct diseases due to their different cells of origins, histology and treatment responses. Therefore, the identification of EOC subtype-specific biomarkers that can early detect the disease should be clinically beneficial. Exosomes are extracellular vesicles secreted by different types of cells and carry biological molecules, which play important roles in cell-cell communication and regulation of various biological processes. Multiple studies have proposed that exosomal miRNAs present in the circulation are good biomarkers for non-invasive early detection of cancer. In this review, the potential use of exosomal miRNAs as early detection biomarkers for EOCs and their accuracy are discussed. We also review the differential expression of circulating exosomal miRNAs and cell-free miRNAs between different biofluid sources, i.e., plasma and serum, and touch on the issue of endogenous reference miRNA selection. Additionally, the current clinical trials using miRNAs for detecting EOCs are summarized. In conclusion, circulating exosomal miRNAs as the non-invasive biomarkers have a high potential for early detection of EOC and its subtypes, and are likely to be clinically important in the future.
first_indexed 2024-03-10T06:42:37Z
format Article
id doaj.art-9ddf9033000f44478a87e12af33e0422
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T06:42:37Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-9ddf9033000f44478a87e12af33e04222023-11-22T17:31:50ZengMDPI AGBiomedicines2227-90592021-10-01910143310.3390/biomedicines9101433Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian CancerMeng-Shin Shiao0Jia-Ming Chang1Arb-Aroon Lertkhachonsuk2Naparat Rermluk3Natini Jinawath4Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandDepartment of Computer Science, National Chengchi University, Taipei 11605, TaiwanDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandDepartment of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandRamathibodi Comprehensive Cancer Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandFailure to detect early-stage epithelial ovarian cancer (EOC) is a major contributing factor to its low survival rate. Increasing evidence suggests that different subtypes of EOC may behave as distinct diseases due to their different cells of origins, histology and treatment responses. Therefore, the identification of EOC subtype-specific biomarkers that can early detect the disease should be clinically beneficial. Exosomes are extracellular vesicles secreted by different types of cells and carry biological molecules, which play important roles in cell-cell communication and regulation of various biological processes. Multiple studies have proposed that exosomal miRNAs present in the circulation are good biomarkers for non-invasive early detection of cancer. In this review, the potential use of exosomal miRNAs as early detection biomarkers for EOCs and their accuracy are discussed. We also review the differential expression of circulating exosomal miRNAs and cell-free miRNAs between different biofluid sources, i.e., plasma and serum, and touch on the issue of endogenous reference miRNA selection. Additionally, the current clinical trials using miRNAs for detecting EOCs are summarized. In conclusion, circulating exosomal miRNAs as the non-invasive biomarkers have a high potential for early detection of EOC and its subtypes, and are likely to be clinically important in the future.https://www.mdpi.com/2227-9059/9/10/1433exosomemiRNAbiomarkersepithelial ovarian cancerliquid biopsy
spellingShingle Meng-Shin Shiao
Jia-Ming Chang
Arb-Aroon Lertkhachonsuk
Naparat Rermluk
Natini Jinawath
Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
Biomedicines
exosome
miRNA
biomarkers
epithelial ovarian cancer
liquid biopsy
title Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
title_full Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
title_fullStr Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
title_full_unstemmed Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
title_short Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
title_sort circulating exosomal mirnas as biomarkers in epithelial ovarian cancer
topic exosome
miRNA
biomarkers
epithelial ovarian cancer
liquid biopsy
url https://www.mdpi.com/2227-9059/9/10/1433
work_keys_str_mv AT mengshinshiao circulatingexosomalmirnasasbiomarkersinepithelialovariancancer
AT jiamingchang circulatingexosomalmirnasasbiomarkersinepithelialovariancancer
AT arbaroonlertkhachonsuk circulatingexosomalmirnasasbiomarkersinepithelialovariancancer
AT naparatrermluk circulatingexosomalmirnasasbiomarkersinepithelialovariancancer
AT natinijinawath circulatingexosomalmirnasasbiomarkersinepithelialovariancancer